Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03429543
Recruitment Status : Active, not recruiting
First Posted : February 12, 2018
Last Update Posted : August 9, 2022
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 4, 2022
Estimated Study Completion Date : May 26, 2023